Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
activities of daily living
activities of daily living scale
adverse drug reaction
agitation
akathisia
alpha methyldopa hydrazine
Alzheimer's disease
amiodarone
amphotericin B
anticholinergic drugs
anticonvulsants
anticonvulsants, cognitive function with
anticonvulsants, untoward effects of
antidepressant
anxiolytic agents
asterixis
ataxia
ataxia, cerebellar
ataxia, truncal
ataxic gait
autonomic dysfunction
basal ganglia
basal ganglia, lesion of
benign essential tremor
bethanechol
bradykinesia
brain transplantation
burning paresthesia
buspirone
butyrophenone
calcium antagonist
calcium antagonist, side effects of
CAT scan
CAT scan, abnormal
CAT scan, contrast enhanced
CAT scan, emission
CAT scan, emission, abnormal
central nervous system, infection of
cerebrospinal fluid, MHPG(3-methoxy 4-hydroxyphenyl glycol)
cerebrovascular accident
cerebrovascular accident, acute management of
chemotherapy, CNS treatment and complications with
chlorpromazine
cholinergic drug
chorea
cinnarizine
clozapine
cognition
complications
contrast agents, neurotoxicity of
creatine phosphokinase(CPK)elevated
cyanide poison
dementia
depression
diltiazem
diplopia
diquat
disulfiram
dopamine antagonist
drug abuse
drug abuse, neurologic complications of
drug induced neurologic disorders
drug interactions
drug overdose
dyskinesia
dyskinesia, buccal lingual facial
dystonia
dystonia, drug induced
dystonic reaction, acute
ecstasy
emergencies, neurologic
emergency room
encephalopathy
enzyme inhibition
epidemiology of neurology
facial movement disorder
falling
fetal tissue
fever
flunarizine
fluorouracil
fluoxetine
fluvoxamine
GM1 ganglioside
haloperidol
headache
headache, treatment of
hemiballismus
hemichorea
herbicide
hexane
HMGcoA reductase inhibitors
huffing
human immunodeficiency virus type 1
Huntington's chorea
hyperthermia
iatrogenic neurologic disorders
inclusion bodies, eosinophilic cytoplasmic
intellectual deficit
L-dopa
L-dopa, potentiators of
lenticular nucleus, lesion of
lenticular nucleus, lesion of, bilateral
Lewy body
Lewy body disease, diffuse
lipid lowering agent
lithium
locus ceruleus, lesion of
lovastatin
manganese intoxication
medical-legal aspects of neurology
memory, impairment of
mental status, abnormal
meperidine
metoclopramide
migraine, prophylaxis
migraine, treatment of
misdiagnosis
mortality
movement disorder
movement disorder, drug induced
movement disorder, extrapyramidal
movement disorder, treatment of
MPTP
MRI
MRI, abnormal
multiple system atrophy
myoclonus
naproxen
neuroleptic
neuroleptic malignant syndrome
neuroleptic, atypical
neuropathology
neuropathology, brain
neuroprotective agents
neurotoxic
neurotoxin
nonsteroidal anti-inflammatory drug
nursing home
nystagmus
occupational neurologic disorders
octreotide
olanzapine
old age, neurology of
ophthalmoplegia
paresthesias
paresthesias, facial
Parkinson disease
Parkinson disease, arteriosclerotic
Parkinson disease, diagnosis
Parkinson disease, differential diagnosis of
Parkinson disease, drug induced
Parkinson disease, exacerbation
Parkinson disease, misdiagnosis
Parkinson disease, progression
Parkinson disease, surgical treatment of
Parkinson disease, treatment of
Parkinson disease, unmasked
Parkinsonism hyperpyrexia syndrome
Parkinsonism multiple-system atrophy
Parkinsonism syndrome
paroxetine
paroxysmal nonkinesigenic dyskinesia
phenothiazine
poison, neurologic problems with
prognosis
progressive supranuclear palsy
psychiatric disorder
psychiatric problems in neurologic disorders
psychosis
putamen, lesion of
putamen, lesion of, bilateral
quetiapine
Rabbit syndrome
renal failure
review article
rhabdomyolysis
rigidity
risperidone
seizure
seizure, treatment of
selective serotonin reuptake inhibitors
serotonin syndrome
sertraline
sinemet
single photon emission computed tomography
sodium valproate
sodium valproate, toxicity
solvent
stridor
subarachnoid hemorrhage
subarachnoid hemorrhage, treatment of
substantia nigra tissue
tardive dyskinesia
tardive dyskinesia, treatment of
tardive dystonia
tetrabenazine
tic
toxins, nervous system
transient neurologic deficit
treatment of neurologic disorder
tremor
tremor, jaw
tricyclic antidepressant
vasospasm, cerebral
verapamil
vision, blurred
wheelchair
Showing articles 1250 to 1300 of 1606 << Previous Next >>

Parkinson's Disease:Sensory & Motor Problems in Arms & Hands
Neurol 37:951-956, Schneider,J.S.,et al, 1987

Early Combination of Bromocriptine & Levodopa in the Treatment of Parkinson's Disease:A 5-Year Follow-up
Neurol 37:826-828, Rinne,U.K., 1987

Bromocriptine Induced Impotence in Parkinson's Disease
BMJ 295:367-368, Cleves,L., 1987

Forms of Dystonia in Patients with Parkinson's Disease
Neurol 37:1009-1011, Kidron,D.&Melamed,E., 1987

Clinical & Biochemical Correlates of Bradyphrenia in Parkinson's Disease
Neurol 37:1130-1134, Mayeux,R.,et al, 1987

Neuropathologic & Clinical Features of Parkinson's Disease in Alzheimer's Disease Patients
Neurol 37:754-760, Ditter,S.M.&Mirra,S.S., 1987

Adrenal Grafts for Parkinson's Disease
Letter, NEJM 317:1091-10931987., , 1987

Transplantation in Parkinson's Disease:Two Cases of Adrenal Medullary Grafts to the Putamen
Ann Neurol 22:457-468, Lindvall,O.,et al, 1987

Neural Transplants:Are We Ready
Ann Neurol 22:455-456, Joynt,R.J.&Gash,D.M., 1987

Management of Parkinson's Disease
BMJ 294:1393-1396, Gibberd,F.B., 1987

Parkinson's Disease & Motor Fluctuations:Long-Acting Carbidopa. Levodopa (CR-4-Sinemet)
Neurol 37:875-878, Goetz,C.G.,et al, 1987

Controlled-Release Levodopa/Carbidopa. II. Sinemet CR4 Treatment of Response Fluctuations in Parkinson's Disease
Neurol 37:1607-1612, Cedarbaum,J.M.,et al, 1987

Controlled Release Levodopa-Carbidopa (CR-5) in the Management of Parkinsonian Motor Fluctuations
Arch Neurol 44:1010-1012, Juncos,J.L.,et al, 1987

Dietary Influence on the Antiparkinsonian Response to Levodopa
Arch Neurol 44:1003-1005, Juncos,J.L.,et al, 1987

Plasma Levels of Amino Acids Correlate with Motor Fluctuations in Parkinsonism
Arch Neurol 44:1006-1009, Pincus,J.H.&Barry,K.M., 1987

Dietary Therapy for Motor Fluctuations in Parkinson's Disease
Arch Neurol 44:1119-1121, Kurlan,R., 1987

Pathophysiol Clin Assess of Motor Symptoms in PD, Jankovic in Handbook of Parkinson's Disease, Ed W. C. Koller
New York 1987, p. 118-120, 475-488., Marcel Dekker,Inc., 1987

Parkinson's Disease & Myasthenia Gravis:Adverse Effect of Trihexyphenidyl on Neuromuscular Transmission
Neurol 37:832-833, Ueno,S.,et al, 1987

Parkinson's Disease & Pregnancy
Neurol 37:1245-1249, Golbe,L.I., 1987

Parkinson's Disease & Megacolon:Concentric Hyaline Inclusions (Lewy Bodies) in Enteric Ganglion Cells
Neurol 37:1253-1255, Kupsky,W.J.,et al, 1987

Levodopa Methyl Ester Treatment of Parkinson's Disease
Neurol 37:1242-1245, Juncos,J.L.,et al, 1987

Raised Cerebrospinal-Fluid Copper Concentration in Parkinson's Disease
Lancet 2:238-241, Pall,H.E.,et al, 1987

Giant Middle Cerebral Aneurysm Presenting as Hemiparkinsonism
JNNP 50:1075, Gross,M., 1987

Pathophysiology & Clinical Assessment of Motor Symptoms in Parkinson's Disease
In Handbk of Parkinson's Disease, Marcel Dekker, Inc, New York, p997., Jankovic,J., 1987

Parkinsonism Following Dystonia in Three Patients
Movement Disorders 1:151-157, Katchen,M.&Duvoisin,R.C., 1986

Dystonia-Parkinson Syndrome:Differential Effects of Levodopa and Dopamine Agonists
Clin Neuropharmacol 9:298-302, Klawans,H.L.&Paleologos,N., 1986

Dystonia in Untreated Parkinsonism
Clin Neuropharmacol 9:293-297, LeWitt,P.A.,et al, 1986

Smoking & Parkinson's Disease, Search for a Dose-Response Relationship
Arch Neurol 43:774-778, Golve,L.I.,et al, 1986

Cigarette Smoking & Parkinson's Disease
Neurol 36:1490-1496, Baron,J.A., 1986

Mental Disorders in Parkinson's Disease
RI Med Jour 69:323-326, Rafal,R., 1986

Brain Dopamine Metabolism in Patients with Parkinson's Disease Measured with Positron Emission Tomography
JNNP 49:853-860, Leenders,K.L.,et al, 1986

A Case of Parkinsonism Following Striatal Lacunar Infarction
JNNP 49:1087-1088, Friedman,A.,et al, 1986

Hereditary Dystonia-Parkinsonism Syndrome of Juvenile Onset
Neurol 36:1424-1428, Nygaard,T.C.&Duvoisin,R.C., 1986

Pathologic Correlates of Dementia in Parkinson's Disease
Arch Neurol 43:991-995, Chui,H.C.,et al, 1986

Alzheimer's Disease, Parkinson's Disease, & Motoneurone Disease:Abiotropic Interaction Between Ageing & Environment
Lancet 2:1067-1068, Calne,D.B.,et al, 1986

Neuropeptides in Neurological Disease
Ann Neurol 20:547-565, Beal,M.F.&Martin,J.B., 1986

Levodopa in Restless Legs
Lancet 2:426-427, vonScheele,C., 1986

Activation of Epileptiform Activity by Mental Arithmetic
Arch Neurol 43:624-626, Anderson,N.E.&Wallis,W.E., 1986

Paradoxical Cerebral Embolism:Eight Cases
Neurol 36:1356-1360, Biller,J.,et al, 1986

MR Imaging in"Lacunar"Hemiballismus
J Comput Assist Tomogr 10:793-797, Biller,J.,et al, 1986

Subcortical Dementia
BMJ 292:1035-1036, Foster,J.B., 1986

Alzheimer's Disease
NEJM 314:964-973, Katzman,R., 1986

Neural Transplantation:Scientific Gains & Clinical Perspectives
Neurol 36:389-392, Fishman,P.S., 1986

Paraquat & Parkinson's Disease
Neurol 36:1147, Koller,W.C., 1986

Disappearance of Parkinsonian Signs after Spontaneous Vascular"Thalamotomy"
Arch Neurol 43:815-817, Dubois,B.,et al, 1986

Parkinson's Disease
BMJ 293:379-382, Quinn,N.P.&Husain,F.A., 1986

Magnetic Resonance Imaging of the Midbrain in Parkinson's Disease
Ann Neurol 20:744-747, Duguid,J.R.,et al, 1986

MPTP:A Neurotoxin Relevant to the Pathophysiology of Parkinson's Disease, The 1985 George Cotzias Lecture
Neurol 36:250-258, Snyder,S.H.&D'Amato,R.J., 1986

Clinicopath. Conference
Pick's Disease of Brain, with Frontal Lobar Atrophy, Degen of Basal Ganglia, Case 16-1986, NEJM 314:, 101-,1986., 1986

The Clinical Features & Natural History of the Steele-Richardson-Olszewski Syndrome (Prog Supranuclear Palsy)
Neurol 36:1005-1006, Maher,E.R.,et al, 1986



Showing articles 1250 to 1300 of 1606 << Previous Next >>